Fullerton, CANCT04108156Now EnrollingIRB Ready

Diabetic Macular Edema Clinical Trial in Fullerton, CA

Access cutting-edge diabetic macular edema treatment through this clinical trial at a research site in Fullerton. Study-provided care at no cost to qualified participants.

Sponsored by Hoffmann-La Roche

Quick Self-Assessment

See if you qualify for this Fullerton location

Preparing your pre-screening questions...

Expert Care in Fullerton

Access diabetic macular edema specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related diabetic macular edema treatment provided free

Apply for This Fullerton Location

Check if you qualify for this diabetic macular edema clinical trial in Fullerton, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Fullerton

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Fullerton site if eligible
  4. 4Begin participation

About This Diabetic Macular Edema Study in Fullerton

This study will evaluate the efficacy, safety, and Pharmacokinetics (PK) of the PDS with ranibizumab in participants with DME when treated every 24 weeks (Q24W) compared with intravitreal (IVT) ranibizumab 0.5 milligrams (mg) every 4 weeks (Q4W). The substudy will evaluate safety of re-implanting the updated PDS with ranibizumab and the refill-exchange procedures following re-implantation in participants with DME who were previously enrolled in the main study, GR40550. Up to 100 participants fr

Sponsor: Hoffmann-La Roche

Who Can Participate

Inclusion Criteria

Age ≥18 years at time of signing informed consent form (ICF)
Documented diagnosis of diabetes mellitus (Type 1 or Type 2)
Glycated haemoglobin (HbA1c) level of ≤10% within 2 months prior to screening or at screening Study eye
Macular thickening secondary to DME involving the center of the fovea with CST ≥325 micrometer (µm) on SD-OCT at screening
BCVA score of 78 to 25 letters (20/32 to 20/320 approximate Snellen equivalent)

Exclusion Criteria

High-risk PDR
Active intraocular inflammation (grade trace or above)
Suspected or active ocular or periocular infection of either eye
Uncontrolled ocular hypertension or glaucoma and any such condition the investigator determines may require a glaucoma-filtering surgery during a patient's participation in the study
Cerebrovascular accident or myocardial infarction within 6 months prior to randomization
Atrial fibrillation diagnosis or worsening within 6 months prior to randomization
Uncontrolled b

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Fullerton?

Yes, this clinical trial (NCT04108156) has an active research site in Fullerton, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Diabetic Macular Edema Treatment Options in Fullerton, CA

If you're searching for diabetic macular edema treatment options in Fullerton, CA, this clinical trial (NCT04108156) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Fullerton research site is actively enrolling participants for this clinical trial. You'll receive care from experienced diabetic macular edema specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all diabetic macular edema clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Fullerton, CA

See all essential tremor clinical trials recruiting in Fullerton — not just this study.

Browse Essential Tremor Trials in Fullerton

Ready to Join in Fullerton?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Fullerton, CA